Drawing for VEDIUS

USPTO serial 87766670

VEDIUS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NADELMAN, ANDREA KOYNER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VEDIUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Frank V. Gallucci

Frank V. Gallucci FUJIFILM Holdings America Corporation200 Summit Lake DriveValhalla, NY 10595UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Cell cultures used in industry and science; mammalian cell cultures and viral vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industriesACTIVE—
040Processing and manufacturing of viral vectors, cell cultures, viral vaccines and gene therapy products for use in biotechnology industries to the order and specification of others; manufacture, processing and production of viral vaccines and gene therapy products for use in the biotechnology industries to the order and specification of othersACTIVE—
042Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and viral vectors in the field of biotechnology; process development, namely, development of processes for the use of mammalian cell cultures and viral vectors in the manufacture of viral vaccines and gene therapy products; project studies relating to the use of mammalian cell cultures and viral vectors in the field of viral vaccines and gene therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 18, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 18, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 28, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 26, 2021EX4GSOU EXTENSION 4 GRANTED—
Jul 26, 2021EXT4SOU EXTENSION 4 FILED—
Jul 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 20, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 18, 2021EX3GSOU EXTENSION 3 GRANTED—
Feb 18, 2021EXT3SOU EXTENSION 3 FILED—
Feb 18, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 31, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2020EX2GSOU EXTENSION 2 GRANTED—
Jul 29, 2020EXT2SOU EXTENSION 2 FILED—
Jul 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 22, 2020EXT1SOU EXTENSION 1 FILED—
Jan 22, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 17, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 2, 2019TMBNTTAB RELEASE CASE TO TRADEMARKS—
Aug 2, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Aug 2, 2019OP.DOPPOSITION DISMISSED NO. 999999—
Jul 26, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 26, 2018OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jun 26, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 26, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 6, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 18, 2018ALIEASSIGNED TO LIE—
May 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 8, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 8, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 8, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 8, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 8, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 8, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 8, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 3, 2018DOCKASSIGNED TO EXAMINER—
Feb 2, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 26, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance